DESCRIPTION

FLEXOST is indicated for the treatment and prevention of osteoarthritis. Its composition is formulated from natural products Glucosamine sulfate 220mg, chondroitin 220mg.

OVERDOSAGE

Single doses up to 7 grams have not presented any more adverse events then normal dosages. From clinical studies the likelihood of overdosing is unknown and unlikely.

MISUSE POTENTIAL

No potential for misuse has been experienced in pre marketing clinical studies or during post marketing events.

USE IN SPECIAL POPULATIONS

Pregnancy

No adequate and well controlled studies with FLEXOST have been conducted in pregnant women.  Because animal reproductive studies are not always predicative of human response FLEXOST during pregnancy is not recommended. 

Nursing Mothers

It is not known if FLEXOST is secretes in human milk.  Therefore, FLEXOST should not be taken by nursing women. 

Pediatric Use

FLEXOST has not been studied in pediatric patients below the age of 16 years. There is not enough scientific evidence to recommend the use of glucosamine in children.